Chesley Taft & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $265K | Buy |
596
+110
| +23% | +$49K | 0.01% | 310 |
|
|
2025
Q1 | $236K | Buy |
+486
| New | +$236K | 0.01% | 320 |
|
|
2021
Q4 | – | Sell |
-3,154
| Closed | -$572K | – | 303 |
|
|
2021
Q3 | $572K | Sell |
3,154
-660
| -17% | -$120K | 0.03% | 221 |
|
|
2021
Q2 | $769K | Hold |
3,814
| – | – | 0.04% | 197 |
|
|
2021
Q1 | $821K | Sell |
3,814
-4,575
| -55% | -$985K | 0.05% | 182 |
|
|
2020
Q4 | $1.98M | Sell |
8,389
-3,050
| -27% | -$721K | 0.13% | 124 |
|
|
2020
Q3 | $3.11M | Buy |
11,439
+1,682
| +17% | +$458K | 0.22% | 92 |
|
|
2020
Q2 | $2.83M | Buy |
9,757
+7,740
| +384% | +$2.25M | 0.22% | 93 |
|
|
2020
Q1 | $480K | Sell |
2,017
-25
| -1% | -$5.95K | 0.04% | 188 |
|
|
2019
Q4 | $447K | Buy |
2,042
+493
| +32% | +$108K | 0.03% | 216 |
|
|
2019
Q3 | $262K | Buy |
+1,549
| New | +$262K | 0.02% | 243 |
|